From Ion Channel Gating Pore Currents to International Genomic Medicine Initiatives in Neuromuscular Diseases

SPEAKER
Michael Hanna is Professor of Clinical Neurology and Director at the UCL Institute of Neurology, Queen Square. He is a Consultant Neurologist at the National Hospital for Neurology. In 2001 he established and leads the NHS England highly specialised clinical and diagnostic service for muscle channelopathies; working with a highly skilled multidisciplinary team of clinicians, geneticists and channel biophysicists enabling accurate diagnosis and treatment for patients nationally. He established and led the MRC Centre for Neuromuscular diseases from 2008-2020, which developed a successful nationally coordinated experimental medicine, research training and genetic research platform. In 2019 he led a bid for £5m to establish the MRC International Centre for Genomic Medicine in Neuromuscular Diseases spanning 14 centres in five counties. He has published over 500 peer-reviewed articles; and is a Fellow and Council member of the Academy of Medical Sciences.

www.cnmd.ac.uk
iris.ucl.ac.uk/iris/browse/profile?upi=MGHAN52